Cargando…

Commentary: Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation

Detalles Bibliográficos
Autor principal:	Sigalov, Alexander B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026307/ https://www.ncbi.nlm.nih.gov/pubmed/32117302 http://dx.doi.org/10.3389/fimmu.2020.00173

Ejemplares similares

Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor Targeted to Endothelium Decreases Cell Activation
por: Gibot, Sébastien, et al.
Publicado: (2019)

Inhibition of Triggering Receptor Expressed on Myeloid Cells 1 Ameliorates Inflammation and Macrophage and Neutrophil Activation in Alcoholic Liver Disease in Mice
por: Tornai, David, et al.
Publicado: (2018)

The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke
por: Gervois, Pascal, et al.
Publicado: (2019)

Identification of Extracellular Actin As a Ligand for Triggering Receptor Expressed on Myeloid Cells-1 Signaling
por: Fu, Lei, et al.
Publicado: (2017)

Triggering Receptor Expressed on Myeloid Cell 2 R47H Exacerbates Immune Response in Alzheimer’s Disease Brain
por: Korvatska, Olena, et al.
Publicado: (2020)

Triggering Receptor Expressed on Myeloid Cells-1 Agonist Regulates Intestinal Inflammation via Cd177(+) Neutrophils
por: Seo, Dong Hyuk, et al.
Publicado: (2021)

The Diagnostic Value of Triggering Receptor Expressed on Myeloid Cells-1 in Post-Traumatic Bacterial Endophthalmitis
por: Tang, Qiuyang, et al.
Publicado: (2023)

The C-type Lectin Receptor CLECSF8 (CLEC4D) Is Expressed by Myeloid Cells and Triggers Cellular Activation through Syk Kinase
por: Graham, Lisa M., et al.
Publicado: (2012)

Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy
por: Katsumoto, Atsuko, et al.
Publicado: (2022)

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2021)

Regulation of Human Macrophage M1–M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1
por: Raggi, Federica, et al.
Publicado: (2017)

Corrigendum: Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia
por: Hussein, Brwa Ali, et al.
Publicado: (2022)

Commentary: PIRs Mediate Innate Myeloid Cell Memory to Nonself MHC Molecules
por: Cai, Zhenlong, et al.
Publicado: (2021)

Triggering Receptors Expressed on Myeloid Cells 2 Promotes Corneal Resistance Against Pseudomonas aeruginosa by Inhibiting Caspase-1-Dependent Pyroptosis
por: Qu, Wenting, et al.
Publicado: (2018)

Commentary: The Expression of CD123 Can Decrease with Basophil Activation: Implications for the Gating Strategy of the Basophil Activation Test
por: Chirumbolo, Salvatore
Publicado: (2016)

Targets for chimeric antigen receptor T-cell therapy of acute myeloid leukemia
por: Schorr, Christopher, et al.
Publicado: (2022)

Triggering Receptor Expressed on Myeloid Cells-1 Signaling: Protective and Pathogenic Roles on Streptococcal Toxic-Shock-Like Syndrome Caused by Streptococcus suis
por: Han, Li, et al.
Publicado: (2018)

A Window of Opportunity: Targeting Cancer Endothelium to Enhance Immunotherapy
por: Duru, Gizem, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
por: Leukes, Vinzeigh, et al.
Publicado: (2020)

Elementary Steps in T Cell Receptor Triggering
por: Dushek, Omer
Publicado: (2012)

The Rate of Interleukin-1β Secretion in Different Myeloid Cells Varies with the Extent of Redox Response to Toll-like Receptor Triggering
por: Carta, Sonia, et al.
Publicado: (2011)

Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
por: Weber, Rebekka, et al.
Publicado: (2018)

Dendritic Cell Activating Receptor 1 (DCAR1) Associates With FcεRIγ and Is Expressed by Myeloid Cell Subsets in the Rat
por: Daws, Michael R., et al.
Publicado: (2019)

Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
por: Hou, Aohan, et al.
Publicado: (2020)

Vascular Endothelium as a Target of Immune Response in Renal Transplant Rejection
por: Piotti, Giovanni, et al.
Publicado: (2014)

Editorial: Targeting Myeloid Cells to Fight Cancer
por: Hollmén, Maija, et al.
Publicado: (2019)

Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
por: He, Ying, et al.
Publicado: (2021)

Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival
por: Cheng, Baoying, et al.
Publicado: (2021)

Toxoplasma effector-induced ICAM-1 expression by infected dendritic cells potentiates transmigration across polarised endothelium
por: Ross, Emily C., et al.
Publicado: (2022)

Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells
por: Ganesan, Sridharan, et al.
Publicado: (2019)

Targeting myeloid villains in the treatment with immune checkpoint inhibitors in gastrointestinal cancer
por: Kudo-Saito, Chie, et al.
Publicado: (2022)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)

Potential for Targeting Myeloid Cells in Controlling CNS Inflammation
por: Ifergan, Igal, et al.
Publicado: (2020)

Regulatory Effects of Histone Deacetylase Inhibitors on Myeloid-Derived Suppressor Cells
por: Cui, Yudan, et al.
Publicado: (2021)

In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients
por: Sanchez-Correa, Beatriz, et al.
Publicado: (2017)

Protective Role of Myeloid Cells Expressing a G-CSF Receptor Polymorphism in an Induced Model of Lupus
por: Sivakumar, Ramya, et al.
Publicado: (2018)

Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
por: Alban, Tyler J., et al.
Publicado: (2020)

IFN-γ transforms the transcriptomic landscape and triggers myeloid cell hyperresponsiveness to cause lethal lung injury
por: Verma, Atul K., et al.
Publicado: (2022)

Commentary: Allergen and Epitope Targets of Mouse-Specific T Cell Responses in Allergy and Asthma
por: Virtanen, Tuomas, et al.
Publicado: (2019)

Arginase in the Vascular Endothelium: Friend or Foe?
por: Lucas, Rudolf, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_iqkc8vq9ef4raikkc5j92rtpsl